Zymeworks Inc. (ZYME)

Healthcare · Biotechnology · NASDAQ

Zymeworks Inc. (ZYME) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.67B and a free-cash-flow yield of -2.0%. Over the most recent reported fiscal year, revenue grew 38.9%.

Market cap	$1.67B
Trailing P/E	—
FCF yield	-2.0%
Revenue growth (YoY)	+38.9%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ZYME data on Nama Insights →